Michael G. Muto

No ORCID on file · 7 papers in corpus · active 1989-2018

Study types

  • article 5
  • case-report 1
  • other 1

Condition tags

  • mesh:D004715 3
  • endometriosis 1
  • endometrioma 1
article 2018
·doi:10.1186/s13048-018-0391-2

BACKGROUND: Extracellular vesicles (EVs) are considered as a new class of resources for potential biomarkers. We analyzed expression of specific mRNA and miRNA in EVs derived from ovarian cancer ascites and the ideal controls, peritoneal fl…

article 2016
Gynecologic oncology ·doi:10.1016/j.ygyno.2016.05.036
article 2015
·doi:10.1097/01.aog.0000463644.75425.0d

INTRODUCTION: Hysterectomy for endometrial cancer is increasingly performed by laparoscopic surgical technique. Same-day discharge is safe, cost-saving, and acceptable to patients undergoing laparoscopic hysterectomy, but concerns about inc…

article 2010
·doi:10.1007/s11701-010-0222-y
case-report 2005
The New England journal of medicine ·doi:10.1056/NEJMcpc059013
article 2004
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine ·doi:10.7863/jum.2004.23.2.307

OBJECTIVE: The purpose of this study was to determine the histologic correlate of small echogenic foci in the ovary and to assess for any association with endometriosis or endosalpingiosis. METHODS: Women planning to have a normal ovary sur…

other 1989
Gynecologic oncology ·doi:10.1016/0090-8258(89)90169-8

Twenty patients with recurrent or persistent epithelial ovarian cancer failing conventional therapies were treated with a single intraperitoneal injection of iodine-131-labeled OC 125 monoclonal antibody. Rare acute side effects were nausea…